secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2022-10-13T23:59:59+00:00
Accession:  0001193125-22-262140
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Acadia appoints Adora Ndu to board, increases size to nine directors
--------------------------------------------------------------------

- Board increased from 8 to 9 members; Adora Ndu, Pharm.D., J.D. appointed effective Oct 12, 2022.
- Dr. Ndu serves as Class I director with term expiring at 2023 Annual Meeting.
- Receives standard director compensation: stock option and RSU award each with $150,000 fair value.
- Will not initially serve on any board committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522262140/0001193125-22-262140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522262140/d412468d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-262140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer